Our Latest News

Cambridge, UK and Cambridge, MA – Tuesday 16th February 2021, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new antibody discovery platform, Galaxy™, that offers significant advantages over...

Cambridge, UK – January 23, 2020 BioMed Realty (“BioMed Realty” or the “Company”), a Blackstone portfolio company and a leading provider of real estate solutions to the life sciences community, and RxCelerate, one of the leading out-sourced drug discovery and...

RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today that it has acquired UK-based molecular modelling company Prosarix.   Originally founded in 2006, Prosarix has built a reputation as one of the...

CAMBRIDGE, England, October 31, 2018 (Newswire.com)  RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today it has opened UK-based chemistry operations at The University of Warwick. The new operation...

Cambridge, UK – January 23, 2020 BioMed Realty (“BioMed Realty” or the “Company”), a Blackstone portfolio company and a leading provider of real estate solutions to the life sciences community, and RxCelerate, one of the leading out-sourced drug discovery and...

Cambridge, UK and Cambridge, MA – 8th May 2018, 1pm BST RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today it has hired Nick Tait as group Chief Financial Officer and also completed the...